AstraZeneca LP (AZN) Raided By European Antitrust Officials
12/3/2010 9:36:53 AM
More...
|
FDA Panel Backs AstraZeneca LP (AZN)'s Drug, Vandetanib, For Rare Thyroid Cancer but Asked to Rethink Drug Dosage
12/3/2010 7:03:37 AM
More...
|
Prometheus Laboratories Inc. Extends Distribution Agreement for ENTOCORT(R) EC (budesonide) Capsules with AstraZeneca LP (AZN)
12/1/2010 7:21:45 AM
More...
|
AstraZeneca LP (AZN) Loses Canada Court Case Over Generic Nexium
6/17/2010 6:57:16 AM
More...
|
AstraZeneca LP (AZN) Secures Approval For Two New Dosage Strengths Of Atacand Plus
2/9/2009 3:59:22 PM
More...
|
Xenome Ltd Grants MedImmune License to xdiscover(TM) Venom Peptide Library
1/8/2009 11:39:32 AM
More...
|
AstraZeneca LP (AZN) Awards Infosys Technologies Multi-Year, Multi-Million Dollar Global Services Deal
12/15/2008 8:43:29 AM
More...
|
AstraZeneca LP (AZN) Drug For Seizures Fatal In Some Patients, Mayo Clinic Study
10/29/2008 7:03:21 AM
More...
|
National Comprehensive Cancer Network, Abraxis BioScience, Inc. And AstraZeneca LP (AZN) Announce Collaboration To Conduct Anti-Cancer Drug Studies
10/7/2008 8:53:20 AM
More...
|
AstraZeneca LP (AZN) Discontinues LEXXEL (enalapril maleate-felodipine ER) Tablets
12/28/2007 9:01:27 AM
More...
|
|